Dimitri Azar is an American ophthalmologist, professor, inventor and businessman who has founded Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. [1] [2] The Twenty Twenty products were ultimately transferred to Santen and Verily in September 2024. Azar served as a board member of Novartis and a member of the scientific advisory board of Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018, and is currently Distinguished Professor and Executive Dean Emeritus. [3] [4]
Azar received his medical degree from the American University of Beirut, Lebanon. [3] Azar practiced at the Wilmer Eye Institute at the Johns Hopkins Hospital School of Medicine, [5] and completed his fellowship and residency training at the Massachusetts Eye and Ear Infirmary at Harvard Medical School, [6] where he was a tenured professor of ophthalmology (2003–2006) and senior scientist at the Schepens Eye Research Institute. [7]
Azar also holds an honorary master's degree from Harvard, as well as an Executive Master of Business Administration from the University of Chicago Booth School of Business. [3]
After serving as tenured professor at Harvard Medical School, Azar joined UIC as a professor of ophthalmology, bioengineering and pharmacology, [3] where he also served as head of the Department of Ophthalmology and Visual Sciences and B.A. Field Endowed Chair of Ophthalmologic Research. [7] He has published more than 500 scientific articles, chapters and patents with over 20,000 citations. He is a member of the American Ophthalmological Society, [8] former president of the Chicago Ophthalmological Society, [3] [9] president-elect of the Chicago Medical Society, and former Trustee of the Association of Research in Vision and Ophthalmology (ARVO). [10] [3]
Azar serves as Senior Advisor at Verily. Until recently, he was the founder and chief executive officer of Twenty Twenty Therapeutics, a joint venture between Verily Life Sciences and Santen. [1] [2]
He was a non-executive member of Novartis' Board of Directors from 2012 until 2019. [3] [11] He was also a member of the Audit and Compliance Committee and the Research & Development Committee.
Azar was a senior director of ophthalmological innovation at Verily, where ophthalmological projects include the development of smart contact lenses, including lenses designed to assist those with presbyopia and an intraocular lens. [12] [13] [14] He was on the board of Verb Surgical Inc. [15] and sits on the board of the Tear Film and Ocular Surface Society in the US. [16] He also sits on the board of Jellisee and the Cure Blindness Project (aka, Himalayan Cataract Project).
Azar is an internationally recognized ophthalmic surgeon and prolific researcher. He has been named one of The Best Doctors in America and one of the Castle Connolly Top Doctors in America annually since 1994. [3] He holds multiple committee positions with the American Academy of Ophthalmology, is a member of the American Ophthalmological Association and sits on the board of trustees of the Chicago Ophthalmological Society and the Association of Research in Vision and Ophthalmology. He has received multiple leadership awards, including the 2009 Lans Distinguished Award from the International Society of Refractive Surgery, and the University of Illinois at Chicago Scholar Award. [3] [17] Azar was awarded the Life Achievement award by the American Academy of Ophthalmology for his sustained services to the organization. [18] The International Society of Refractive Surgery, in 2013, awarded him with the Jose Barraquer Award and has also received the University of Illinois at Chicago Scholar Award, and the Distinguished Professor award in 2013. [19] In 2016, Weill Cornell Medical College awarded Azar with the John McLean Medal. [20]
From 2008 to 2010, Chicago Magazine, in cooperation with Castle Connelly Medical Ltd., listed Azar as one of the top doctors in ophthalmology. [21] In 2016, he received the Castroviejo Award in recognition of exceptional contributions in support of the Society's mission from the American Academy of Ophthalmology, as well as the Ramon Castroviejo Award from the Cornea Society. [20] [22] On June 27, 2019, he received an honorary doctoral degree from the University of Balamand, in recognition of his significant lifetime achievements as a world-renowned scholar, creative inventor, academician, and eye surgeon. [23]
This section of a biography of a living person does not include any references or sources .(January 2021) |
Year | Award | Awarded by |
---|---|---|
1991 | Teacher of the Year Award | Massachusetts Eye and Ear Infirmary |
1993 | Teacher of the Year Award | The Wilmer Institute, Johns Hopkins University |
1996 | Resident Teaching Recognition Award | The Wilmer Institute Johns Hopkins University |
1994-1996 | Top Doctor | Baltimore Magazine, Baltimore, MD |
1996 | Voted among Top 10 U.S. Refractive Surgeons | Ophthalmology Times |
1998 | American Academy of Ophthalmology Honor Award | American Academy of Ophthalmology |
1999, 2001 | Top Doctor, Ophthalmology/ Refractive Surgery | Boston Magazine (Castle Connolly regional database) |
2003 | Top Doctor, Ophthalmology | Boston Magazine (Castle Connolly regional database) |
2004 | Senior Achievement Award | American Academy of Ophthalmology |
2005 | Top 50 Opinion Leaders | Cataract & Refractive Surgery Today |
2005 | Top 10 Ophthalmologists in Greater Boston area | Boston Herald Supplement |
2007 | Alcon Research Institute Award | Alcon Research Institute |
2005-2010 | Best Doctor in America® | www.bestdoctors.com |
2006-2016 | America's Top Doctor | Castle Connolly national database |
2008 | Maurice F. Rabb, MD/Jose F. Pulido, MD Medical Student Award | University of Illinois at Chicago |
2009 | University Scholar Award | University of Illinois at Chicago, Chicago, IL |
2010 | Silver Fellow, Outstanding service to the eye and vision community [24] | Association of Research in Vision and Ophthalmology |
2011 | Beta Gamma Sigma Honor Society | University of Chicago Booth School of Business |
2013 | Jose Barraquer Award [25] | International Society of Refractive Surgery, American Academy of Ophthalmology |
2014 | Gold Fellow, Outstanding service to the eye and vision community [26] | Association of Research in Vision and Ophthalmology |
2016 | Ramon Castroviejo Award [27] | Cornea Society |
2016 | John McLean Medal [28] | Weill Cornell Medical College |
2016 | Distinguished Service Award | Association of Research in Vision and Ophthalmology |
2018 | Distinguished Research Achievement Awardee 2018 | HMS Department of Ophthalmology Annual Meeting and Alumni Reunion |
2019 | SAFIR Lecturer, “Intelligence artificielle en ophthalmology.” | SFO, May 11, 2019 |
2019 | Guest of Honor | New England Ophthalmological Society, September 6, 2019 |
2023 | Dastgheib Pioneer Award in Ocular Innovation [29] | Duke University, October 12, 2023 |
Ophthalmology is a clinical and surgical specialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.
A pterygium of the eye is a pinkish, roughly triangular tissue growth of the conjunctiva onto the cornea of the eye. It typically starts on the cornea near the nose. It may slowly grow but rarely grows so large that it covers the pupil and impairs vision. Often both eyes are involved.
Far-sightedness, also known as long-sightedness, hypermetropia, and hyperopia, is a condition of the eye where distant objects are seen clearly but near objects appear blurred. This blur is due to incoming light being focused behind, instead of on, the retina due to insufficient accommodation by the lens. Minor hypermetropia in young patients is usually corrected by their accommodation, without any defects in vision. But, due to this accommodative effort for distant vision, people may complain of eye strain during prolonged reading. If the hypermetropia is high, there will be defective vision for both distance and near. People may also experience accommodative dysfunction, binocular dysfunction, amblyopia, and strabismus. Newborns are almost invariably hypermetropic, but it gradually decreases as the newborn gets older.
LASIK or Lasik, commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and astigmatism. LASIK surgery is performed by an ophthalmologist who uses a femtosecond laser or a microkeratome to create a corneal flap to expose the corneal stroma and then an excimer laser to reshape the corneal stroma in order to improve visual acuity.
A microkeratome is a precision surgical instrument with an oscillating blade designed for creating the corneal flap in LASIK or ALK surgery. The normal human cornea varies from around 500 to 600 μm in thickness; and in the LASIK procedure, the microkeratome creates an 83 to 200 μm thick flap. The microkeratome uses an oscillating blade system, which has a blade that oscillates horizontally as the blade travels vertically for a precise cut. This piece of equipment is used all around the world to cut the cornea flap. The microkeratome is also used in Descemet's stripping automated endothelial keratoplasty (DSAEK), where it is used to slice a thin layer from the back of the donor cornea, which is then transplanted into the posterior cornea of the recipient. It was invented by Jose Barraquer and Cesar Carlos Carriazo in the 1950s in Colombia.
Radial keratotomy (RK) is a refractive surgical procedure to correct myopia (nearsightedness). It was developed in 1974 by Svyatoslav Fyodorov, a Russian ophthalmologist. It has been largely supplanted by newer, more accurate operations, such as photorefractive keratectomy, LASIK, Epi-LASIK and the phakic intraocular lens.
Refractive surgery is an optional eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea (keratomileusis), lens implantation or lens replacement. The most common methods today use excimer lasers to reshape the curvature of the cornea. Refractive eye surgeries are used to treat common vision disorders such as myopia, hyperopia, presbyopia and astigmatism.
José Ignacio Barraquer Moner was a Spanish ophthalmologist and inventor born in Barcelona who did most of his life's work in Bogotá, Colombia.
Epikeratophakia is a refractive surgical procedure in which a lamella of a donor cornea is transplanted onto the anterior surface of the patient's cornea. A lamellar disc from a donor cornea is placed over the de-epithelialized host cornea and sutured into a prepared groove on the host cornea. Indications include treatment of keratoconus, refractive errors like myopia and high hypermetropia including aphakia, which cannot be corrected with conservative methods.
Pedram Hamrah is a German-American ophthalmologist and immunologist. He obtained his M.D. from the University of Cologne, Germany.
Peter S. Hersh is an American ophthalmologist, researcher, and specialist in LASIK eye surgery, keratoconus, and diseases of the cornea. He co-authored the article in the journal Ophthalmology that presented the results of the study that led to the first approval by the U.S. Food and Drug Administration (FDA) of the excimer laser for the correction of nearsightedness in the United States. Hersh was also medical monitor of the study that led to approval of corneal collagen crosslinking for the treatment of keratoconus. He was the originator, in 2015, of CTAK for keratoconus, patent holder, and co-developer.
A corneal inlay is a device which is surgically implanted in the cornea of the eye as a treatment for presbyopia. Successful installation results in reducing dependence on reading glasses, so that the user can more easily engage in everyday tasks such as using a mobile phone, reading store shelf prices and working on a computer.
Sheraz Daya is a British ophthalmologist. Daya founded the Centre for Sight in 1996, and works in stem-cell research and sight restoration and correction surgery.
Jeewan Singh Titiyal is an Indian ophthalmologist, credited with the first live cornea transplant surgery by an Indian doctor. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine.
Dr Amar Agarwal M.S., FRCS, F.R.C.Ophth is an Indian ophthalmologist and chairman and managing director of Dr. Agarwal's Eye Hospital and Eye Research Centre in India, which includes 190 + eye hospitals. He is the recipient of the Best Doctor award of the State government from then Chief Minister of Tamil Nadu J Jayalalithaa on 15 August 2014. He is also the past President of the International Society of Refractive Surgery (ISRS) and Secretary General of the Intraocular Implant and Refractive Society of India (IIRSI).
Farhad Hafezi is a prominent Swiss eye surgeon and researcher. Hafezi first gained recognition as a leading retina researcher in 1994, having been the first to discover a gene responsible for light-induced retinal degeneration. However, he changed his research focus to the cornea in 2003, and it is this work, particularly on corneal collagen cross-linking (CXL), which he helped pioneer, and advanced laser refractive surgery that he is internationally known for today. Hafezi's current clinical and laboratory research is focused on gaining a better understanding of the cornea. His research group at the University of Zurich has three main research foci:
Noel Alpins is an Australian ophthalmologist who developed the Alpins method of astigmatism analysis used in refractive, corneal, and cataract surgery, used in the research of LASIK.
John Marshall is a British medical scientist and inventor. Currently he is the Frost Professor of Ophthalmology at the Institute of Ophthalmology UCL and Emeritus Professor King's College London. He is a pioneer of laser eye surgery.
Santosh Gajanan Honavar is an Indian ophthalmologist and is currently the Honorary General Secretary of the All India Ophthalmological Society; Director of Medical Services ; Director, Department of Ocular Oncology and Oculoplasty at Centre for Sight, Hyderabad; and Director, National Retinoblastoma Foundation. He was the Editor of the Indian Journal of Ophthalmology and Indian Journal of Ophthalmology - Case Reports, the official journals of the All India Ophthalmological Society from 2017 to 2023.
The American Society of Cataract and Refractive Surgery (ASCRS), a professional society for surgeons specializing in eye surgery, based in Fairfax, VA, was founded in 1974. It is distinct from its sister organization, the American Society of Ophthalmic Administrators (ASOA), which concerns itself with the business management, including insurance reimbursement and marketing, of ophthalmic practices in the United States. Both associations hold annual meetings or conventions as well as publishing proceedings.